Predictmedix AI Inc.
PMED
CNSX
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -45.87% | 87.60% | |||
| Depreciation & Amortization | 2.86% | -87.13% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -45.11% | 54.61% | |||
| Operating Income | 45.11% | -54.61% | |||
| Income Before Tax | 54.43% | 20.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 54.43% | 20.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 54.43% | 20.17% | |||
| EBIT | 45.11% | -54.61% | |||
| EBITDA | 45.87% | -341.25% | |||
| EPS Basic | 61.54% | 31.58% | |||
| Normalized Basic EPS | 50.00% | -33.33% | |||
| EPS Diluted | 61.54% | 31.58% | |||
| Normalized Diluted EPS | 50.00% | -33.33% | |||
| Average Basic Shares Outstanding | 10.46% | 16.12% | |||
| Average Diluted Shares Outstanding | 10.46% | 16.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||